Achieve Life Sciences is trading 6.76% higher at $8.21, with no confirmed company-specific announcement explaining the move. - Its latest identified company news was a September 28 announcement that 52-week cytisinicline study data will be presented at CHEST 2026 on October 18–21; no source explicitly linked it to the September 30 move. - Broader indices are only modestly higher, leaving the cause unclear.